|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0101 - 0.0129|
|52 Week Range||0.0100 - 0.0385|
|Beta (5Y Monthly)||1.70|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NEW YORK, March 17, 2022--Manhattan Scientifics Inc. (OTCQB: MHTX ), announces positive early results from Imagion Biosystems Cancer Diagnostic human study.
NEW YORK, November 01, 2021--Manhattan Scientifics Inc. (OTC: QB), initially funded and is the current owner of more that 50 million shares of Imagion Biosystems Ltd. (IBX.AX).